Interestingly, an elevated MACC1 expression was detected in patients with a history of tumor recurrence in another study focusing on intrahepatic and hilar cholangiocarcinoma patients, confirming that MACC1 can be used as an independent prognostic biomarker for the OS of Klatskin tumor patients [12]. This evidence concerns the gene MACC1 and Klatskin's tumor.